688510.SHG Wuxi Hyatech Co. Ltd. A
- Market cap
- CNY 5.05B
- P/E
- 48.6x
- P/B
- 3.88x
- ROE
- 8.4%
- Dividend yield
- 1.17%
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.
Is 688510.SHG undervalued?
Graham number688510.SHG trades 189.5% above its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Wuxi Hyatech Co. Ltd. A fundamental analysis
No fundamental analysis for Wuxi Hyatech Co. Ltd. A yet.
Wuxi Hyatech Co. Ltd. A stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Wuxi Hyatech Co. Ltd. A
Wuxi Hyatech Co.,Ltd., together with its subsidiaries, research, develops, manufactures, and sells aero-engines and gas turbine components; and medical orthopedic implant forgings in China and internationally. The company offers compressor blades; rotating and structural parts, including rectifiers, casing, turbine, compressor, and bladed disks; and other products. It also provides medical orthopedic implant forgings for artificial hip joints, femoral stems, acetabular cups,…
Full company profileWuxi Hyatech Co. Ltd. A financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 2 quarters up to Jun 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Wuxi Hyatech Co. Ltd. A annual financial statements (CNY; K = thousand, M = million, B = billion, T = trillion)
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 31.0M | 97.6M | 161M | 258M | 301M | 313M | 363M | 544M | 703M | 699M | 747M |
| Gross Profit | 12.0M | 28.2M | 54.0M | 102M | 132M | 93.7M | 97.7M | 183M | 252M | 699M | 281M |
| Operating Income | -27.8M | -6.30M | 13.1M | 45.4M | 68.2M | 21.5M | 15.1M | 96.0M | 136M | 113M | 176M |
| EBITDA | -15.2M | 7.85M | 30.4M | 69.1M | 101M | 64.8M | 63.9M | 153M | 217M | 186M | 124M |
| Net Income | -17.7M | -7.32M | 14.0M | 42.2M | 59.9M | 24.3M | 20.1M | 90.2M | 127M | 102M | 103M |
| EPS | -0.13 | -0.05 | 0.08 | 0.22 | 0.31 | 0.09 | 0.08 | 0.35 | 0.49 | 0.40 | 0.39 |
| Balance Sheet | |||||||||||
| Total Assets | 241M | 320M | 534M | 628M | 1.21B | 1.36B | 1.44B | 1.59B | 1.92B | 2.02B | 1.96B |
| Total Liabilities | 103M | 139M | 168M | 221M | 270M | 357M | 441M | 496M | 735M | 769M | 703M |
| Shareholders' Equity | 138M | 178M | 365M | 406M | 940M | 961M | 958M | 1.05B | 1.14B | 1.21B | 1.22B |
| Cash & Short-term Investments | 32.8M | 79.2M | 78.3M | 97.1M | 541M | 526M | 319M | 218M | 321M | 318M | 220M |
| Total Debt | 59.0M | 78.0M | 30.6M | 58.3M | 81.4M | 105M | 116M | 69.4M | 213M | - | - |
| Cash Flow | |||||||||||
| Operating Cash Flow | -29.8M | -2.22M | 38.4M | 57.5M | 52.6M | 65.6M | 52.0M | 121M | 210M | 180M | - |
| Capital Expenditure | 39.5M | 26.3M | 113M | 118M | 101M | 137M | 231M | 218M | 196M | 154M | 159M |
| Free Cash Flow | -69.2M | -28.5M | -74.2M | -60.8M | -48.0M | -71.2M | -179M | -97.5M | 14.3M | 25.6M | -15.3M |
| Ratios | |||||||||||
| ROE | -12.8% | -4.1% | 3.8% | 10.4% | 6.4% | 2.5% | 2.1% | 8.6% | 11.1% | 8.5% | 8.4% |
| ROA | -7.3% | -2.3% | 2.6% | 6.7% | 4.9% | 1.8% | 1.4% | 5.7% | 6.6% | 5.1% | 5.2% |
| Net Profit Margin | -57.0% | -7.5% | 8.7% | 16.4% | 19.9% | 7.8% | 5.5% | 16.6% | 18.0% | 14.6% | 13.7% |
| Debt to Equity | 0.43x | 0.44x | 0.08x | 0.14x | 0.09x | 0.11x | 0.12x | 0.07x | 0.19x | - | - |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Wuxi Hyatech Co. Ltd. A dividends
- Dividend yield
- 1.17%
- Forward dividend
- 0.20 CNY
- Payout ratio
- 57.6%
- Ex-dividend date
- May 25, 2026
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | CNY 58.8M | 0.23 | 57.6% |
| 2024 | CNY 58.1M | 0.23 | 45.9% |
| 2023 | CNY 3.99M | 0.02 | 4.4% |
| 2022 | CNY 32.1M | 0.13 | 159.9% |
| 2021 | CNY 4.59M | 0.02 | 18.9% |
| 2020 | CNY 3.98M | 0.02 | 6.7% |
| 2019 | CNY 1.62M | 0.01 | 3.8% |
| 2018 | 3.63M | 0.02 | 25.9% |
| 2017 | 4.06M | 0.03 | - |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Who owns Wuxi Hyatech Co. Ltd. A
- Insiders 32.54%
- Institutions 12.67%
- Public & others 54.79%
- Shares outstanding 260M
- Free float 183M
Wuxi Hyatech Co. Ltd. A company profile
- Company name
- Wuxi Hyatech Co. Ltd. A
- Ticker
- 688510.SHG
- ISIN
- CNE1000077M3
- Exchange
- Shanghai Stock Exchange
- Sector
- Industrials
- Industry
- Aerospace & Defense
- Employees
- 698
- Fiscal year end
- December
- Address
- No. 35, Xindongan Road, Wuxi, China, 214142
- Phone
- 86 510 8189 3691
- Website
- hyatech.cn
About Wuxi Hyatech Co. Ltd. A
Wuxi Hyatech Co.,Ltd., together with its subsidiaries, research, develops, manufactures, and sells aero-engines and gas turbine components; and medical orthopedic implant forgings in China and internationally. The company offers compressor blades; rotating and structural parts, including rectifiers, casing, turbine, compressor, and bladed disks; and other products. It also provides medical orthopedic implant forgings for artificial hip joints, femoral stems, acetabular cups, artificial knee joints, tibial trays, and artificial trauma bone plates. The company serves aero engine and medical orthopedic joint manufacturers. Wuxi Hyatech Co.,Ltd. was founded in 2013 and is based in Wuxi, China.
Wuxi Hyatech Co. Ltd. A management
4- Mr. Hongda ZhuGeneral Manager · born 1971
- Mr. Wei Wei WuCFO & Accounting Supervisor · born 1980
- Mr. Hongxiang JingDeputy General Manager · born 1987
- Mr. Guangyi ZhangDeputy General Manager · born 1983